HRT Financial
CTSO icon

HRT Financial’s Cytosorbents Corp CTSO Stock Holding History

HRT Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
1,606
+900
+127% +$9.5K ﹤0.01% 3971
2026
Q1 		$7K Buy
+706
New +$9.6K ﹤0.01% 3653
2025
Q1 		– Sell
-575
Closed -$10K – 2651
2024
Q4 		$10K Buy
+575
New +$11.3K ﹤0.01% 2281
2023
Q4 		– Sell
-513
Closed -$19K – 2427
2023
Q3 		$19K Buy
+513
New +$29.4K ﹤0.01% 2076
2021
Q3 		– Sell
-778
Closed -$117K – 3366
2021
Q2 		$117K Buy
+778
New +$131K ﹤0.01% 2556
2021
Q1 		– Sell
-763
Closed -$121K – 2757
2020
Q4 		$121K Buy
+763
New +$128K ﹤0.01% 1606

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial's CTSO Position: Q2 2026 in Review

HRT Financial increased its Cytosorbents Corp (CTSO) stake by 127% in Q2 2026, buying an estimated $9.5K and bringing the position to 1,606 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3971.

HRT Financial first reported a position in CTSO in Q4 2020 and has held it in 6 quarters since. The position peaked at $121K in Q4 2020. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • HRT Financial held 1,606 shares of Cytosorbents Corp worth $12K as of Q2 2026.
  • HRT Financial bought 900 Cytosorbents Corp shares in Q2 2026, an estimated $9.5K.
  • Cytosorbents Corp made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3971 holding.
  • HRT Financial first reported a position in Cytosorbents Corp in Q4 2020 and has held it in 6 quarters since.
  • HRT Financial's Cytosorbents Corp position peaked at $121K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.